Stimuli‐Responsive Nanocarriers for Transcytosis‐Based Cancer Drug Delivery
Significant challenges persist in enhancing the delivery efficiency of tumor nanomedicines, predominantly due to the difficulty of successfully surpassing pathophysiological barriers. Enhancing tumor penetration of nanomedicines in such conditions represents a pivotal goal in advancing anticancer na...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2024-03-01
|
Series: | Advanced NanoBiomed Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/anbr.202300125 |